Secondaries announced 8.5.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: IMS Health-BLOCK Symbol: IMS Price: Last trade $32.10 Trade Date: 8/6 Shares: 20 million Underwriter(s) J.P. Morgan, Morgan Stanley Rating=Subscription Needed[…]